About this document

Referensi 2 by Lershito is a document available to read on EtoBox.

This review discusses the evolution of nonsteroidal anti-inflammatory drugs (NSAIDs), focusing on the development of selective COX-2 inhibitors that aim to minimize gastrointestinal side effects while addressing inflammation. It highlights the differences between COX-1 and COX-2 enzymes, the risks associated with both non-selective and selective NSAIDs, and the ongoing research to create safer COX-2 inhibitors. The article emphasizes the need for new compounds that can effectively manage inflammation with r

Author

Lershito

Language

EN